STENTARELLI, Chiara
 Distribuzione geografica
Continente #
NA - Nord America 6.944
EU - Europa 3.861
AS - Asia 2.897
SA - Sud America 428
AF - Africa 89
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 4
Totale 14.231
Nazione #
US - Stati Uniti d'America 6.833
GB - Regno Unito 2.050
SG - Singapore 919
CN - Cina 774
SE - Svezia 368
HK - Hong Kong 336
IT - Italia 326
BR - Brasile 325
VN - Vietnam 308
DE - Germania 300
FI - Finlandia 188
TR - Turchia 164
UA - Ucraina 149
RU - Federazione Russa 127
FR - Francia 125
IN - India 80
CA - Canada 57
BG - Bulgaria 51
KR - Corea 51
BD - Bangladesh 45
ID - Indonesia 39
MX - Messico 36
IQ - Iraq 33
ZA - Sudafrica 33
AR - Argentina 28
JP - Giappone 22
MY - Malesia 22
SI - Slovenia 22
NL - Olanda 20
CO - Colombia 19
EC - Ecuador 18
PL - Polonia 18
PH - Filippine 17
BE - Belgio 16
ES - Italia 16
IE - Irlanda 14
AE - Emirati Arabi Uniti 12
CL - Cile 12
PK - Pakistan 12
LT - Lituania 10
MA - Marocco 10
SA - Arabia Saudita 10
VE - Venezuela 10
EG - Egitto 9
PE - Perù 9
AT - Austria 8
RO - Romania 8
CZ - Repubblica Ceca 7
ET - Etiopia 7
JO - Giordania 7
PT - Portogallo 7
TH - Thailandia 7
TN - Tunisia 7
CR - Costa Rica 6
SK - Slovacchia (Repubblica Slovacca) 6
CH - Svizzera 5
DZ - Algeria 5
IR - Iran 5
NG - Nigeria 5
DK - Danimarca 4
EU - Europa 4
IL - Israele 4
LB - Libano 4
AU - Australia 3
AZ - Azerbaigian 3
BO - Bolivia 3
GH - Ghana 3
GR - Grecia 3
JM - Giamaica 3
NP - Nepal 3
SN - Senegal 3
UZ - Uzbekistan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BB - Barbados 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
HU - Ungheria 2
KW - Kuwait 2
LK - Sri Lanka 2
LU - Lussemburgo 2
MM - Myanmar 2
NI - Nicaragua 2
OM - Oman 2
PY - Paraguay 2
TW - Taiwan 2
ZW - Zimbabwe 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
CG - Congo 1
CI - Costa d'Avorio 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
GA - Gabon 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
KE - Kenya 1
KG - Kirghizistan 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
Totale 14.218
Città #
Southend 1.786
Ashburn 643
Santa Clara 636
Singapore 598
Fairfield 549
Woodbridge 465
Chandler 459
Hong Kong 335
Houston 300
Jacksonville 287
San Jose 255
Ann Arbor 248
Dearborn 241
Seattle 226
Wilmington 220
Beijing 217
Cambridge 199
Nyköping 159
London 129
Helsinki 119
Modena 116
Hefei 111
Los Angeles 107
Izmir 104
Chicago 101
New York 100
Dallas 96
Ho Chi Minh City 88
The Dalles 88
Princeton 70
Hanoi 67
Council Bluffs 62
Munich 58
Eugene 51
Sofia 51
Seoul 50
Shanghai 49
San Diego 45
Lauterbourg 42
São Paulo 38
Moscow 36
Salt Lake City 36
Bremen 32
Buffalo 27
Boardman 26
Redwood City 25
Chennai 22
Columbus 22
Frankfurt am Main 22
Tampa 21
Milan 20
Jakarta 19
Turku 19
Phoenix 17
Orem 16
Johannesburg 15
Warsaw 15
Atlanta 14
Baghdad 13
Da Nang 13
Dublin 13
Tokyo 13
Toronto 13
Brussels 12
Falls Church 12
Halifax 12
Mexico City 12
San Francisco 12
Stockholm 12
Bologna 11
Faenza 11
Falkenstein 11
Haiphong 11
Manchester 11
Medellín 11
Paris 11
Rio de Janeiro 11
Rome 11
Elk Grove Village 10
Lancaster 10
Montreal 10
Norwalk 10
Sterling 10
Bengaluru 9
Brooklyn 9
Guangzhou 9
Nanjing 9
Poplar 9
Tuscaloosa 9
Basingstoke 8
Dong Ket 8
Kunming 8
Amsterdam 7
Chengdu 7
Denver 7
Detroit 7
Ferrara 7
Fremont 7
Hải Dương 7
Quito 7
Totale 10.389
Nome #
Late presentation increases risk and costs of non-infectious comorbidities in people with HIV: An Italian cost impact study 801
Multidrug-resistant tuberculosis outbreak in an Italian prison: Tolerance of pyrazinamide plus levofloxacin prophylaxis and serial interferon gamma release assays 784
A frailty index predicts survival and incident multimorbidity independent of markers of HIV disease severity 462
Erectile dysfunction is more common in young to middle-aged HIV-infected men than in HIV-uninfected men. 433
Nonalcoholic Fatty Liver Disease in HIV-Infected Patients Referred to a Metabolic Clinic: Prevalence, Characteristics, and Predictors 405
Human Immunodeficiency Virus Is the Major Determinant of Steatosis and Hepatitis C Virus of Insulin Resistance in Virus-associated Fatty Liver Disease. 389
Aging with HIV vs. HIV Seroconversion at Older Age: A Diverse Population with Distinct Comorbidity Profiles 348
Low testosterone is associated with poor health status in men with human immunodeficiency virus infection: a retrospective study 323
Abstract: P784 ANTIRETROVIRAL THERAPY AND LIPODYSTROPHY AS PREDICTORS OF SUB-CLINICAL ATHEROSCLEROSIS 312
Intact parathyroid hormone levels are associated with increased carotid intima media thickness in HIV infected patients 310
Epicardial adipose tissue and coronary artery calcium predict incident myocardial infarction and death in HIV-infected patients 310
The natural history of HIV-associated lipodystrophy in the changing scenario of HIV infection 289
Atazanavir and lopinavir profile in pregnant women with HIV: tolerability, activity and pregnancy outcomes in an observational national study 278
HIV patients undergoing second generation antipsychotics show high cardiovascular disease burden 276
Body Composition changes in ageing HIV infected patients: the complex interplay between low muscle mass, lipodystrophy and osteopenia. 273
MR techniques in the qualitative analysis of liver steatosis: the potential in the differentiation between steatohepatatis and steatosis 271
Prediction of hard cardiovascular events in HIV patients 271
Clinical and epidemiological features of HIV/AIDS infection among migrants at first access to healthcare services as compared to Italian patients in Italy: a retrospective multicentre study, 2000-2010. 271
Magnetic resonance for quantitative assessment of liver steatosis: a new potential tool to monitor antiretroviral-drug-related toxicities. 270
American College of Cardiology pooled equations and DAD algorithm to predict freedom from cardiovascular events in HIV patients 268
Body Mass Index and Weight Gain in Pregnant Women With HIV: A National Study in Italy 267
Full Viral Suppression, Low-Level Viremia, and Quantifiable Plasma HIV-RNA at the End of Pregnancy in HIV-Infected Women on Antiretroviral Treatment 265
MR quantitative biomarkers of non-alcoholic fatty liver disease: technical evolutions and future trends 264
Changes with menopause in the distribution of frailty index (FI) in HIV infected women. 260
Prevalence and predictors of preclinical coronary heart disease in post-menopause period 253
Tenofovir accelerates bone mass loss of the lumbar spine in the first years of menopause in HIV infected women. 252
Combined use of waist and thigh circumference to identify high-risk,, abdominally obese HIV+ patients. 251
ANTIRETROVIRAL THERAPY AND LIPODYSTROPHY AS PREDICTORS OF SUB-CLINICAL ATHEROSCLEROSIS 250
Should we screen for NAFLD/NASH in HIV patients? 246
Multimorbidity and functional status assessment 243
Vitamin D3 supplementation decreases the risk of diabetes mellitus among patients with HIV infection. 239
Metabolic alterations in HIV-infected pregnant women: moving to metabolic tailoring of antiretroviral drugs. 238
Multiecho MR sequences and high-resolution magic angle spinning (HRMAS)ex-vivo spectroscopy in the qualitative analysis and differentiationbetween steatohepatitis and steatosis 236
Predictors of transitions in frailty severity and mortality among people aging with HIV 232
Non-alcoholic Fatty Liver Disease: a HR-MAS analysis 226
HIV-Associated Lipodystrophy: Impact of Antiretroviral Therapy 225
HIGH PREVALENCE OF VITAMIN D DEFICIENCY IN A COHORT OF HIV INFECTED PREGNANT AND NON-PREGNANT WOMEN OF CHILDBEARING AGE 218
HIGH PREVALENCE OF VITAMIN D DEFICIENCY IN A COHORT OF HIV INFECTED PREGNANT WOMEN AND ITS IMPACT ON PREGNANCY OUTCOME 211
MR techiniques in the quantitative assessment of liver steatosis 208
Health transitions in HIV-seropositive individulas undergoing NRTI-based and NRTI-sparing treatment strategies. 206
How do frailty mediate pathway leading to disability 198
Two methods of measuring frailty among people aging with HIV 198
HR-MAS NMR SPECTROSCOPY FOR CHARACTERIZATION OF STEATOSIC LIVER: FAT QUANTIFICATION FOR A SPECTROSCOPIC DIFFERENTIATION BETWEEN STEATOSIS AND STEATOHEPATITIS 196
Birth defects in a national cohort of pregnant women with HIV infection in Italy, 2001-2011 187
Limited occurrence of new grade 3-4 toxicity events with salvage regimens based on raltegravir and /or maraviroc: 96 weeks data from the ISS NIA cohort study. 181
Tesamorelin for the treatment of excess abdominal fat in HIV-infected individuals with lipodistrophy 178
Menopause in HIV-infected women: somewhat different? 178
Impact of Antiretroviral Medications on Fasting Lipid Parameters 174
Limited occurence of new grade 3-4 toxicity events with salvage regimens based on raltegravir and /or maraviroc: 96 weeks data from the ISS NIA cohort study 165
Clinical evaluation is better than risk prediction algorithms to identify patients who need statin therapy. 164
Renal hyperfiltration and outcome in HIV-infected subjects. 161
Nucleoside reverse-transcriptase inhibitor use, cirrhosis, and end-stage liver disease in HIV-infected patients - Reply to Remtulla and Decker 157
L’epatopatia non alcolica da accumulo di grasso (NAFLD) in HIV: dallo screening al trattamento 54
null 49
Totale 14.374
Categoria #
all - tutte 47.661
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.661


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021368 0 0 0 0 0 0 0 0 0 165 120 83
2021/20221.128 46 159 99 132 19 60 48 72 119 82 160 132
2022/20231.132 118 139 91 117 139 162 9 130 136 20 30 41
2023/2024694 29 47 43 66 155 94 42 85 12 8 43 70
2024/20252.176 65 53 34 158 474 306 144 144 263 76 198 261
2025/20263.744 248 123 312 506 793 276 554 194 386 352 0 0
Totale 14.374